121 related articles for article (PubMed ID: 12124773)
1. Structure-activity relationships of heparin-mimicking compounds in induction of bFGF release from extracellular matrix and inhibition of smooth muscle cell proliferation and heparanase activity.
Benezra M; Ishai-Michaeli R; Ben-Sasson SA; Vlodavsky I
J Cell Physiol; 2002 Sep; 192(3):276-85. PubMed ID: 12124773
[TBL] [Abstract][Full Text] [Related]
2. Laminarin sulfate mimics the effects of heparin on smooth muscle cell proliferation and basic fibroblast growth factor-receptor binding and mitogenic activity.
Miao HQ; Ishai-Michaeli R; Peretz T; Vlodavsky I
J Cell Physiol; 1995 Sep; 164(3):482-90. PubMed ID: 7650058
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of tumor metastasis by heparanase inhibiting species of heparin.
Vlodavsky I; Mohsen M; Lider O; Svahn CM; Ekre HP; Vigoda M; Ishai-Michaeli R; Peretz T
Invasion Metastasis; 1994-1995; 14(1-6):290-302. PubMed ID: 7657522
[TBL] [Abstract][Full Text] [Related]
4. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
[TBL] [Abstract][Full Text] [Related]
5. Exogenous leukocyte and endogenous elastases can mediate mitogenic activity in pulmonary artery smooth muscle cells by release of extracellular-matrix bound basic fibroblast growth factor.
Thompson K; Rabinovitch M
J Cell Physiol; 1996 Mar; 166(3):495-505. PubMed ID: 8600153
[TBL] [Abstract][Full Text] [Related]
6. Oligomannurarate sulfate, a novel heparanase inhibitor simultaneously targeting basic fibroblast growth factor, combats tumor angiogenesis and metastasis.
Zhao H; Liu H; Chen Y; Xin X; Li J; Hou Y; Zhang Z; Zhang X; Xie C; Geng M; Ding J
Cancer Res; 2006 Sep; 66(17):8779-87. PubMed ID: 16951194
[TBL] [Abstract][Full Text] [Related]
7. A synthetic heparin-mimicking polyanionic compound binds to the LDL receptor-related protein and inhibits vascular smooth muscle cell proliferation.
Benezra M; Vogel T; Ben-Sasson SA; Panet A; Sehayek E; Al-Haideiri M; Decklbaum RJ; Vlodavsky I
J Cell Biochem; 2001; 81(1):114-27. PubMed ID: 11180402
[TBL] [Abstract][Full Text] [Related]
8. The cysteine-free fibroblast growth factor 1 mutant induces heparin-independent proliferation of endothelial cells and smooth muscle cells.
Xue L; Shireman PK; Hampton B; Burgess WH; Greisler HP
J Surg Res; 2000 Aug; 92(2):255-60. PubMed ID: 10896831
[TBL] [Abstract][Full Text] [Related]
9. Poly(N-acryl amino acids): a new class of biologically active polyanions.
Bentolila A; Vlodavsky I; Ishai-Michaeli R; Kovalchuk O; Haloun C; Domb AJ
J Med Chem; 2000 Jun; 43(13):2591-600. PubMed ID: 10891119
[TBL] [Abstract][Full Text] [Related]
10. Autocrine production of basic fibroblast growth factor translated from novel synthesized mRNA mediates thrombin-induced mitogenesis in smooth muscle cells.
Cucina A; Borrelli V; Lucarelli M; Sterpetti AV; Cavallaro A; Strom R; Santoro-D'Angelo L; Scarpa S
Cell Biochem Funct; 2002 Mar; 20(1):39-46. PubMed ID: 11835269
[TBL] [Abstract][Full Text] [Related]
11. Lung colonization by and heparanase activity in in vitro transformed 3T3 cells rendered highly tumorigenic by an in vivo passage.
Katz BZ; Ishai-Michaeli R; Zusman T; Vlodavsky I; Witz IP
Invasion Metastasis; 1994-1995; 14(1-6):276-89. PubMed ID: 7657521
[TBL] [Abstract][Full Text] [Related]
12. Novel heparanase-inhibiting antibody reduces neointima formation.
Myler HA; Lipke EA; Rice EE; West JL
J Biochem; 2006 Mar; 139(3):339-45. PubMed ID: 16567398
[TBL] [Abstract][Full Text] [Related]
13. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor.
Cai S; Liu Y; Zheng Shu X; Prestwich GD
Biomaterials; 2005 Oct; 26(30):6054-67. PubMed ID: 15958243
[TBL] [Abstract][Full Text] [Related]
14. Heparanase, heparin and the coagulation system in cancer progression.
Vlodavsky I; Ilan N; Nadir Y; Brenner B; Katz BZ; Naggi A; Torri G; Casu B; Sasisekharan R
Thromb Res; 2007; 120 Suppl 2():S112-20. PubMed ID: 18023704
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of rat smooth muscle cell adhesion and proliferation by non-anticoagulant heparins.
Kazi M; Lundmark K; Religa P; Gouda I; Larm O; Ray A; Swedenborg J; Hedin U
J Cell Physiol; 2002 Dec; 193(3):365-72. PubMed ID: 12384988
[TBL] [Abstract][Full Text] [Related]
16. Coexpression of heparanase, basic fibroblast growth factor and vascular endothelial growth factor in human esophageal carcinomas.
Mikami S; Ohashi K; Katsube K; Nemoto T; Nakajima M; Okada Y
Pathol Int; 2004 Aug; 54(8):556-63. PubMed ID: 15260846
[TBL] [Abstract][Full Text] [Related]
17. Structural determinants of the capacity of heparin to inhibit the proliferation of vascular smooth muscle cells.
Castellot JJ; Beeler DL; Rosenberg RD; Karnovsky MJ
J Cell Physiol; 1984 Sep; 120(3):315-20. PubMed ID: 6746751
[TBL] [Abstract][Full Text] [Related]
18. Heparanase upregulation in high glucose-treated endothelial cells is prevented by insulin and heparin.
Han J; Woytowich AE; Mandal AK; Hiebert LM
Exp Biol Med (Maywood); 2007 Jul; 232(7):927-34. PubMed ID: 17609509
[TBL] [Abstract][Full Text] [Related]
19. Heparanase activity expressed by platelets, neutrophils, and lymphoma cells releases active fibroblast growth factor from extracellular matrix.
Ishai-Michaeli R; Eldor A; Vlodavsky I
Cell Regul; 1990 Oct; 1(11):833-42. PubMed ID: 2088528
[TBL] [Abstract][Full Text] [Related]
20. Sodium spirulan as a potent inhibitor of arterial smooth muscle cell proliferation in vitro.
Kaji T; Okabe M; Shimada S; Yamamoto C; Fujiwara Y; Lee JB; Hayashi T
Life Sci; 2004 Mar; 74(19):2431-9. PubMed ID: 14998720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]